孕期Tdap疫苗接种时机:抗体诱导与胎盘转移效率的动态平衡
比利时前瞻性非随机对照试验纳入96名孕16-32周接种Tdap的孕妇,评估接种时孕龄对母体及新生儿抗体特征和胎盘转移的影响。结果显示分娩时母体总IgG和IgG1(抗PRN、DT、TT)随接种孕龄增加而升高,但脐血抗体谱无显著差异;IgG转移比随孕龄增加普遍下降,功能抗体转移基本不受影响。结论支持现行孕16-32周接种Tdap的推荐。
要点
- 分娩时母体总IgG和IgG1(抗PRN、DT、TT)随接种孕龄增加而升高
- 脐血抗体谱在各接种孕龄组间无显著差异
- IgG转移比随接种孕龄增加普遍下降,功能抗体转移基本不受影响
核心结论
- 分娩时母体Tdap抗体应答谱受接种时机影响,但新生儿出生时抗体谱在研究范围内基本相当。
- 研究结果支持现行孕16-32周接种Tdap的推荐,并强调该窗口的灵活性。
研究设计与样本
- 比利时前瞻性非随机对照试验,96名孕妇在孕16-32周不同孕龄接种Tdap。
- 采集接种前、接种后多时间点及分娩时母血和脐血,检测Tdap特异性总IgG、IgG亚类及Fc介导效应功能,采用多变量分析定义复合免疫模式。
主要发现
- 接种后各队列均观察到稳健免疫应答。
- 分娩时母体总IgG和IgG1(抗PRN、DT、TT)随接种孕龄增加而升高,其他亚类和功能应答基本相当。
- 脐血谱部分平行于母体模式但未达显著性,未检测到接种至分娩间隔的显著效应。
- IgG转移比随孕龄增加普遍下降,功能抗体转移基本不受影响。
- 多变量分析显示接种越晚分娩时母体抗体应答谱越高,而脐血谱基本不受影响。
临床怎么用
- 产前常规保健中可在孕16-32周窗口灵活安排Tdap接种,无需过度担忧接种时机对新生儿抗体谱的显著影响。
局限性
- 研究为非随机设计,样本量96例,结论受研究范围限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tetanus, diphtheria, acellular pertussis (Tdap) vaccination in pregnancy protects newborns against pertussis, but the influence of gestational age (GA) at vaccination on maternal and neonatal immune profiles remains incompletely understood. This study aimed to characterize the effect of GA at Tdap vaccination on several antibody features during pregnancy and at birth, and to assess transplacental antibody transfer. METHODS: 96 pregnant women received Tdap at different GAs between week 16 and 32 within a Belgian, prospective non-randomized controlled trial. Maternal blood was collected pre-vaccination, at multiple timepoints post-vaccination, and at delivery, alongside cord blood at birth. Tdap-specific total IgG and IgG subclasses were evaluated alongside Fc-mediated effector functions. Multivariate analyses were applied to define composite immune patterns. RESULTS: Post-vaccination, robust immune responses were observed across cohorts. At delivery, maternal total IgG and IgG1 against PRN, DT, and TT were higher with later vaccination, whereas other subclasses and functional responses were largely comparable. Cord blood profiles partially paralleled maternal patterns without reaching significance, and no significant effect of vaccination-to-delivery interval was detected. IgG transfer ratios generally declined with advancing GA; functional antibody transfer was largely unaffected. Multivariate analyses highlighted higher maternal antibody response profiles at delivery with later vaccination, while cord blood profiles were generally unaffected. CONCLUSION: Maternal Tdap antibody response profiles at delivery are influenced by vaccination timing, while neonatal antibody profiles at birth appear largely comparable within the limits of the study. These findings support current recommendations for Tdap administration between 16 and 32 weeks of gestation and underscore the flexibility of this window for routine antenatal care.
引用
- De Weerdt L, Thiriard A, Vu Duc I, et al. Timing of maternal Tdap vaccination: A dynamic balance between antibody induction and placental transfer efficiency. Vaccine. 2026. PMID: 42472495. doi:10.1016/j.vaccine.2026.128953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。